Literature DB >> 33752610

Using item response theory (IRT) to improve the efficiency of the Simple Clinical Colitis Activity Index (SCCAI) for patients with ulcerative colitis.

Alissa Walsh1, Rena Cao2, Darren Wong2, Ramona Kantschuster2, Lawrence Matini2, Jean Wilson2, Andrey Kormilitzin3, Matthew South3, Simon Travis2, Sarah Bauermeister3.   

Abstract

BACKGROUND: The SCCAI was designed to facilitate assessment of disease activity in ulcerative colitis (UC). We aimed to interrogate the metric properties of individual items of the SCCAI using item response theory (IRT) analysis, to simplify and improve its performance.
METHODS: The original 9-item SCCAI was collected through TrueColours, a real-time software platform which allows remote entry and monitoring of patients with UC. Data were securely uploaded onto Dementias Platform UK Data Portal, where they were analysed in Stata 16.1 SE. A 2-parameter (2-PL) logistic IRT model was estimated to evaluate each item of the SCCAI for its informativeness (discrimination). A revised scale was generated and re-assessed following systematic removal of items.
RESULTS: SCCAI data for 516 UC patients (41 years, SD = 15) treated in Oxford were examined. After initial item deletion (Erythema nodosum, Pyoderma gangrenosum), a 7-item scale was estimated. Discrimination values (information) ranged from 0.41 to 2.52 indicating selected item inefficiency with three items < 1.70 which is a suggested discriminatory value for optimal efficiency. Systematic item deletions found that a 4-item scale (bowel frequency day; bowel frequency nocturnal; urgency to defaecation; rectal bleeding) was more informative and discriminatory of trait severity (discrimination values of 1.50 to 2.78). The 4-item scale possesses higher scalability and unidimensionality, suggesting that the responses to items are either direct endorsement (patient selection by symptom) or non-endorsement of the trait (disease activity).
CONCLUSION: Reduction of the SCCAI from the original 9-item scale to a 4-item scale provides optimum trait information that will minimise response burden. This new 4-item scale needs validation against other measures of disease activity such as faecal calprotectin, endoscopy and histopathology.

Entities:  

Keywords:  Activity index; Item response theory; Ulcerative colitis

Mesh:

Substances:

Year:  2021        PMID: 33752610      PMCID: PMC7983213          DOI: 10.1186/s12876-021-01621-y

Source DB:  PubMed          Journal:  BMC Gastroenterol        ISSN: 1471-230X            Impact factor:   3.067


  22 in total

Review 1.  Response burden and questionnaire length: is shorter better? A review and meta-analysis.

Authors:  Sindre Rolstad; John Adler; Anna Rydén
Journal:  Value Health       Date:  2011-08-02       Impact factor: 5.725

2.  RDP58 is a novel and potentially effective oral therapy for ulcerative colitis.

Authors:  Simon Travis; Lee Min Yap; Chris Hawkey; Bryan Warren; Mirella Lazarov; Tim Fong; R J Tesi
Journal:  Inflamm Bowel Dis       Date:  2005-08       Impact factor: 5.325

3.  Applying item response theory (IRT) modeling to questionnaire development, evaluation, and refinement.

Authors:  Maria Orlando Edelen; Bryce B Reeve
Journal:  Qual Life Res       Date:  2007-03-21       Impact factor: 4.147

4.  Reliability, effect size, and responsiveness of health status measures in the design of randomized and cluster-randomized trials.

Authors:  Paula Diehr; Lu Chen; Donald Patrick; Ziding Feng; Yutaka Yasui
Journal:  Contemp Clin Trials       Date:  2005-01-27       Impact factor: 2.226

5.  Electronic collection of health-related quality of life data: validity, time benefits, and patient preference.

Authors:  B D Bliven; S E Kaufman; J A Spertus
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

6.  Patient-reported outcome instrument selection: designing a measurement strategy.

Authors:  Claire F Snyder; Maria E Watson; Joseph D Jackson; David Cella; Michele Y Halyard
Journal:  Value Health       Date:  2007 Nov-Dec       Impact factor: 5.725

7.  A simple clinical colitis activity index.

Authors:  R S Walmsley; R C Ayres; R E Pounder; R N Allan
Journal:  Gut       Date:  1998-07       Impact factor: 23.059

Review 8.  Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): the TRIPOD Statement.

Authors:  G S Collins; J B Reitsma; D G Altman; K G M Moons
Journal:  Br J Surg       Date:  2015-02       Impact factor: 6.939

9.  Development of the Qualeffo-31, an osteoporosis-specific quality-of-life questionnaire.

Authors:  N M van Schoor; D L Knol; C A W Glas; R W J G Ostelo; A Leplège; C Cooper; O Johnell; P Lips
Journal:  Osteoporos Int       Date:  2005-12-14       Impact factor: 4.507

10.  The True Colours Remote Symptom Monitoring System: A Decade of Evolution.

Authors:  Sarah M Goodday; Mary-Jane Attenburrow; Lauren Atkinson; Guy Goodwin; Kate Saunders; Matthew South; Clare Mackay; Mike Denis; Chris Hinds; Jim Davies; James Welch; William Stevens; Karen Mansfield; Juulia Suvilehto; John Geddes
Journal:  J Med Internet Res       Date:  2020-01-15       Impact factor: 5.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.